An inflammatory response is a pathological hallmark of amyotrophic lateral sclerosis (ALS), a relentless and devastating degenerative disease of motoneurons. This response is not simply a late consequence of motoneuron degeneration, but actively contributes to the balance between neuroprotection and neurotoxicity; initially infiltrating lymphocytes and microglia slow disease progression, while later, they contribute to the acceleration of disease. Since motor weakness begins in the hindlimbs of ALS mice and only later involves the forelimbs, we determined whether differential protective versus injurious inflammatory responses in the cervical and lumbar spinal cords explained the temporally distinct clinical disease courses between the limbs of these mice. Densitometric evaluation of immunohistochemical sections and quantitative RT-PCR (qRT-PCR) demonstrated that CD68 and CD11c were differentially increased in their spinals cords. qRT-PCR revealed that protective and anti-inflammatory factors, including BDNF, GDNF, and IL-4, were increased in the cervical region compared with the lumbar region. In contrast, the toxic markers TNF-a, IL-1b and NOX2 were not different between ALS mice cervical and lumbar regions. T lymphocytes were observed infiltrating lumbar spinal cords of ALS mice prior to the cervical region; mRNA levels of the transcription factor gata-3 (Th2 response) were differentially elevated in the cervical cord of ALS mice whereas t-bet (Th1 response) was increased in the lumbar cord. These results reinforce the important balance between specific protective/injurious inflammatory immune responses in modulating clinical outcomes and suggest that the delayed forelimb motor weakness in ALS mice is partially explained by augmented protective responses in the cervical spinal cords.
Introduction
The central nervous system (CNS) has traditionally been considered immunologically privileged, but there has been a re-evaluation of this tenet and neuroinflammation is now recognized to be a prominent feature of many classic neurodegenerative disorders including amyotrophic lateral sclerosis (ALS) (Carson et al., 2006; Barbeito et al., 2010) . ALS is an adult-onset, relentlessly progressive neurodegenerative disorder and although numerous pathological processes appear to contribute to motoneuron injury in this inexorable disease, there is a neuroinflammatory response, highlighted by the presence of activated microglia and infiltrating lymphocytes at sites of motoneuron injury, that also contributes to this pathogenic process (Engelhardt et al., 1993; McGeer and McGeer, 2002; Henkel et al., 2004; Boillée et al., 2006; Kassa et al., 2009 ).
Recent evidence suggests that this response is not simply a late consequence of motoneuron degeneration, but actively contributes to the balance between neuroprotection and neurotoxicity; initially activated microglia and infiltrating lymphocytes slow disease progression, while later, they can contribute to the acceleration of disease (Beers et al., 2006 (Beers et al., , 2008 .
As a component of the innate immune system, microglia are of hematopoietic origin and colonize the CNS during early development; microglia are resident macrophages that sample the extracellular space through continuous extension, retraction, and remodeling of their cellular processes (McKercher et al., 1996; Beers et al., 2006; Ransohoff and Perry, 2009) . As primary intrinsic immune effector cells, microglia are involved in virtually all pathological processes of the CNS including inflammatory, neurodegenerative, traumatic, neoplastic, and vascular diseases, and as identified more recently, neuroprotection (Carson et al., 2006; Appel et al., 2010) . Cumulative data suggest that when activated, microglia can produce and release an array of pro-and anti-inflammatory molecules, and may exert either a toxic or protective effect on neurons depending on the physiologic conditions; earlier reports proposed that microglial activation is detrimental to the 0889-1591/$ -see front matter Ó 2010 Elsevier Inc. All rights reserved. doi:10.1016/j.bbi.2010.12.008
